Quantitation of somatostatin receptor type 2 gene expression in neuroblastoma cell lines and primary tumors using competitive reverse transcription-polymerase chain reaction

Clinical Cancer Research

Volumn 2, Issue 10, 1996, Pages 1757-1765

  Sestini, R ^a   Orlando, C ^a   Peri, A ^a   Tricarico, C ^a   Pazzagli, M ^a   Serio, M ^a   Pagani, A ^b   Bussolati, G ^b   Granchi, S ^a   Maggi, M ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOSTATIN RECEPTOR;

ARTICLE; CELL LINE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; NEUROBLASTOMA; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; BINDING SITES; BLOTTING, NORTHERN; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEUROBLASTOMA; PROTO-ONCOGENE PROTEINS C-MYC; RADIOLIGAND ASSAY; RECEPTORS, SOMATOSTATIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; SOMATOSTATIN; SURVIVAL ANALYSIS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 10244222260     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Raulf, F., Perez, J., Hoyer, D., and Bruns, C. Differential expression of five somatostatin receptor subtypes, SSTR1-5, in the CNS and peripheral tissue. Digestion, 55 (Suppl. 3): 46-53, 1994.
2. Reisine, T., and Bell, G. I. Molecular biology of somatostatin receptors. Endocr. Rev., 16: 427-442, 1995.
3. Patel, Y. C., Murthy, K. K., Escher, E. E., Banville, D., Spiess, J., and Srikant, C. B. Mechanism of action of somatostatin: an overview of receptor function and studies of the molecular characterization and purification of somatostatin receptor proteins. Metabolism, 39 (Suppl. 2): 63-69, 1990.
4. Srikant, C. B., and Patel, Y. C. Somatostatin receptors: identification and characterization in rat brain membranes. Proc. Natl. Acad. Sci. USA, 78: 3930-3934, 1981.
5. Tran, V. T., Beal, M. F., and Martin, J B Two types of somatostatin receptors differentiated by cyclic somatostatin analogs. Science (Washington DC), 228: 492-495, 1985.
6. Krenning, E. P., Breeman, W. A. P., Kooij, P. P. M., Lameris, J. S., Bakker, W. H., Koper, J. W., Ausema, L., Reubi, J-C., and Lamberts, S. W. J. Localization of endocrine-related tumours with radioiodinated analogue of somatostatin. Lancet, 1: 242-244, 1989.
7. 3]octreotide: the Rotterdam experience with more than 1000 patients. Eur. J. Nucl. Med., 20: 716-731, 1993.
8. Lamberts, S. W. J., Krenning, E. P., and Reubi, J-C. The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr. Rev., 12: 450-482, 1991.
9. Reubi, J-C., and Laissue, J. A. Multiple actions of somatostatin in neoplastic disease. Trends Pharmacol. Sci., 16: 110-115, 1995.
10. 3]octreotide by mouse and human pituitary tumor cells: increase by unlabeled octreotide. Endocrinology, 136: 3698-3706, 1995.
11. Buscail, L., Delesque, N., Esteve, J-P., Saint-Laurent, N., Prats, H., Clerc, P., Robberecht, D., Bell, G. I., Liebow, C., Schally, A., Vaysse, N., and Susini, C. Stimulation of thyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human somatostatin receptors subtypes SSTR1 and SSTR2. Proc. Natl. Acad. Sci. USA, 91: 2315-2319, 1994.
12. Buscail, L., Esteve, J-P., Saint-Laurent, N., Bertrand, V., Reisine, T., O'Carrol, A. M., Bell, G. I., Schally, A., Vaysse, N., and Susini, C. Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by SSTR2 and SSTR5 somatostatin receptors through different mechanisms. Proc. Natl. Acad. Sci. USA, 92: 1580-1584, 1995.
13. Epelbaum, J., Bertherat, J., Prevost, G., Kordon, C., Meyerhof, W., Wulfsen, I., Richter, D., and Plouin, P-F. Molecular and pharmacological characterization of somatostatin receptor subtypes in adrenal, extradrenal, and malignant pheochromocytomas. J. Clin. Endocrinol. Metab., 80: 1837-1844, 1995.
14. Kubota, A., Yamada, Y., Kagimoto, S., Shimatsu, A., Imamura, M., Tsuda, K., and Imura, H. Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors. J. Chn. Invest., 93: 1321-1325, 1994.
15. Reubi, J-C , Schaer, J. C., Waser, B., and Mengod, G. Expression and localization of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human tumors using in situ hybridization. Cancer Res., 54: 3455-3459, 1994.
16. Maggi, M., Baldi, E., Finetti, G., Franceschelli, F., Brocchi, A., Lanzillotti, R., Serio, M., Camboni, M. G., and Thiele, C. J. Identification, characterization, and biological activity of somatostatin receptors inhuman neuroblastoma cell lines. Cancer Res., 54: 124-133, 1994.
17. Yamada, Y., Post, S. P., Wang, K., Tager, H. S., Bell, G. I., and Seino, S. Cloning and functional characterization of a family of human and mouse somatostatin receptors in brain, gastrointestinal tract, and kidney. Proc. Natl. Acad. Sci. USA, 89: 251-255, 1992.
18. Vikic-Topic, S., Raisch, K. P., Kvols, L. K., and Vuk-Pavlovic, S. Expression of somatostatin receptor subtypes in breast carcinoma, carcinoid tumor, and renal cell carcinoma. J. Clin. Endocrinol. Metab., 80: 2974-2979, 1995.
19. Shimada, H., Chatten, J., Newton, W. A., Jr., Sachs, N., Hamoudi, A. B., Chiba, R., Marsden, H. B., and Misugi, K. Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and age-linked classification of Neuroblastomas. J. Natl. Cancer Inst., 73: 405-416, 1984.
20. Evans, A. E., D'Angio, G. S., and Propert, J. A proposed staging for children with neuroblastoma. Children's Cancer Study Group A. Cancer (Phila.), 27: 374-378, 1971.
21. Chirgwin, J. M., Przybyla, A. E , MacDonald, R. J., and Rutter, W. J. Isolation of biologically active RNA from sources enriched in ribonuclease. Biochemistry, 18: 5294-5297, 1979.
22. Pagani, A., Forni, M., Tonini, G. P., Papotti, M., and Bussolati, G. Expression of members of the chromogranin family in primary neuroblastomas. Diagn. Mol. Pathol., 1: 16-24, 1992.
23. Sugimoto, T., Tatsumi, E., Kemshead, J. T., Helson, L., Green, A. A., and Minowada, J. Determination of cell surface membrane antigens common to both human neuroblastoma and leukemia-lymphoma cell lines by a panel of 38 monoclonal antibodies. J. Natl. Cancer Inst., 73: 51-57, 1984.
24. Helson, L., Member, B., and Helson, C. Importance of clinical exposure on verapamil enhancement of Adryamicin-vincristine cytotoxicity in human neuroblastoma. Cancer Drug Delivery, 1: 303-305, 1984.
25. Sclesinger, H. R., Gerson, J. M., Moorhead, P. S., Maguire, H., and Hummeler, K. Establishment and characterization of human neuroblastoma cell lines. Cancer Res., 36: 3094-3100, 1976.
26. Sclesinger, H. R., Rorke, L., Jameison, R., and Hurrimeler, K. 1981. Neuronal properties of neuroectodermal tumors in vitro. Cancer Res., 41: 2573-2575, 1981.
27. Reynolds, C. P., Biedler, J. L., Spengler, B. A., Reynolds, D. A., Ross, R. A., Frenkel, E. P., and Smith, R. G. Characterization of human neuroblastoma cell lines established before and after therapy. J. Natl. Cancer Inst., 76: 375-387, 1986.
28. Ross, R. A., Spengler, B. A., and Biedler, J. L. Coordinate morphological and biochemical interconversion of human neuroblastoma cells. J. Natl. Cancer Inst., 71: 741-746, 1983.
29. Seeger, R. C., Rayner, S. A., Banerjee, A., Chung, H., Laug, W. E., Neustein, H. B., and Benedict, W. F. Morphology, growth, chromosomal pattern, and fibrinolytic activity of two new human neuroblastoma cell lines. Cancer Res., 37: 1364-1371, 1977.
30. Maggi, M., Barni, T., Orlando, C., Fantoni, G., Finetti, G., Vanelli, G. B., Mancina, R., Gloria, L., Bonaccorsi, L., Yanaghisawa, M., and Forti, G. Endothelin-1 and its receptors in human testis. J. Androl., 16: 213-224, 1995.
31. Diviacco, S., Norio, P., Zentilin, L., Menzo, S., Clementi, M., Biamonti, G., Falaschi, A., and Giacca, M. A novel procedure for quantitative polymerase chain reaction by coamplification of competitive templates. Gene, 122: 3013-3020, 1992.
32. Sestini, R., Orlando, C., Zentilin, L., Gelmini, S., Pinzani, P., Bianchi, S., Selli, C., Giacca, M., and Pazzagli, M. Measuring c-erbB-2 oncogene amplification in fresh and paraffin-embedded tumors by competitive polymerase chain reaction. Clin. Chem., 40: 630-636, 1994.
33. Orlando, C., Sestini, R., Zentilin, L., Gelmini, S., Pinzani, P., Giacca, M., and Pazzagli, M. Image analysis in quantitative PCR. An application for the measurement of c-erbB-2 amplification in DNA from human tumors. J. Biolum. Chemilum , 9: 223-228, 1994.
34. Sestini, R., Orlando, C., Zentilin, L., Lami, D., Gelmini. S., Pinzani, P., Giacca, M., and Pazzagli M. Measurement of gene amplification for c-erbB-2, c-myc, epidermal growth factor receptor, int-2 and N-myc by quantitative PCR with a multiple competitor template. Clin. Chem., 41: 826-832, 1995.
35. Kaplan, E., and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 58: 457-481, 1958.
36. Patel, Y. C., Greenwood, M., Kent, G., Panetta, R., and Srikant, C. B. Multiple gene transcripts of the somatostatin receptor SSTR2: tissue selective distribution and cAMP regulation. Biochem. Biophys. Res. Commun., 192: 288-294, 1993.
37. Cooper, M. J., Hutchins, G. M., Cohen, P. S., Helman, L J., Mennie, R. J., and Israel, M. A. Human neuroblastoma tumors correspond to the arrested differentiation of chromaffin adrenal medullary neuroblasts. Cell Growth & Differ. 1: 149-159, 1990.
38. Brodeur, G. M., Seeger, R. C., Schwab, M., Varmus, H. E., and Bishop, J. P. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science (Washington DC), 224; 1121-1124, 1984.
39. Seeger, R. C., Brodeur, G. M., Sather, H., Dalton, A., Siegel, S. E., Wong, K. Y., and Hammond, D. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N. Engl. J. Med., 318: 1111-1116, 1985.
40. + mobilization. Biochem. Biophys. Res. Commun., 200: 986-992, 1994.
41. Evans, A. E., Baum, E., and Chard, R. Do infants with stage IV-S neuroblastoma need treatments? Arch. Dis. Child., 56: 270-274, 1981.
42. Weiler, R., Meyerson, G , Fischer-Colbrie, R., Laslop, A., PÂhlman, S., Floor, E., and Winkler, H. Divergent changes of chromogranin A/secretogranin II levels in differentiating human neuroblastoma cells. FEES Lett., 265: 27-29, 1990.
43. Moertel, C. L., Reubi, J-C., Scheithauer, B. S., Schaid, D. J., and Kvols, L. K. Expression of somatostatin receptors in childhood neuroblastoma. Am. J. Clin. Pathol., 102: 752-756, 1994.
44. O'Dorisio, M. S., Chen, F., O'Dorisio, T. M., Wray, D., and Qualman, S. J. Characterization of somatostatin receptors in human neuroblastoma tumors. Cell Growth & Differ., 5: 1-8, 1994.
45. Katzenellenbogen, J. A., Colemann, E. R., Hawkins, R. A., Krohn, K. A., Larson, S. M., Mendelsohn, J., Osborne, C. K., Piwnica-Worms, D., Reba, R. C., Siegel, B. A., Welch, M. J., and Shtern, F. Tumor receptor imaging: proceedings of the National Cancer Workshop, review of current work, and prospectives for further investigations. Clin. Cancer Res. 1: 921-932, 1995.